227Th-Affibody molecules (Bayer/Affibody)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name227Th-Affibody molecules (Bayer/Affibody)
Drug Alias Name227Th-Affibody molecules (Affibody)227Th-Affibody molecules (Algeta/Affibody)
ClassificationBiologics
Mechanisms of ActionPlatelet-derived growth factor receptor modulatorsReceptor protein-tyrosine kinase erbB-2 modulators
TargetsPlatelet-derived growth factor receptorReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffibody Medical AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlgeta ASAAffibody Medical ABBayer AG
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A